# Ryerson Holding Corp: financial statements, quarterly

RYZ · NYSE · CIK 1481582 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ryz.md) · [Financials](/companies/ryz/financials.md) · [Filings](/companies/ryz/filings.md) · [Insiders](/companies/ryz/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ryz/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,247](/filings/0000950170-24-118254.md) | [1,112 d](/filings/0001193125-26-062397.md) | [1,239](/filings/0000950170-25-061080.md) | [1,226](/filings/0000950170-25-099646.md) | [1,127](/filings/0001193125-25-253579.md) | [1,007 d](/filings/0001193125-26-062397.md) | [1,136](/filings/0001193125-26-209016.md) | [1,169](/filings/0001193125-26-323769.md) | [1,162](/filings/0001193125-25-253579.md) | [1,105 d](/filings/0001193125-26-062397.md) | [1,567](/filings/0001193125-26-209016.md) | [2,006](/filings/0001193125-26-323769.md) |
| Cost of revenue | $m | [997](/filings/0000950170-24-118254.md) | [865 d](/filings/0001193125-26-062397.md) | [1,022](/filings/0000950170-25-061080.md) | [1,002](/filings/0000950170-25-099646.md) | [925](/filings/0001193125-25-253579.md) | [816 d](/filings/0001193125-26-062397.md) | [931](/filings/0001193125-26-209016.md) | [960](/filings/0001193125-26-323769.md) | [962](/filings/0001193125-25-253579.md) | [936 d](/filings/0001193125-26-062397.md) | [1,278](/filings/0001193125-26-209016.md) | [1,651](/filings/0001193125-26-323769.md) |
| Gross profit | $m | [249](/filings/0000950170-24-118254.md) | [247 d](/filings/0001193125-26-062397.md) | [218](/filings/0000950170-25-061080.md) | [224](/filings/0000950170-25-099646.md) | [202](/filings/0001193125-25-253579.md) | [191 d](/filings/0001193125-26-062397.md) | [204](/filings/0001193125-26-209016.md) | [209](/filings/0001193125-26-323769.md) | [200](/filings/0001193125-25-253579.md) | [169 d](/filings/0001193125-26-062397.md) | [289](/filings/0001193125-26-209016.md) | [355](/filings/0001193125-26-323769.md) |
| Selling, general and administrative | $m | [193](/filings/0000950170-24-118254.md) | [204 d](/filings/0001193125-26-062397.md) | [217](/filings/0000950170-25-061080.md) | [199](/filings/0000950170-25-099646.md) | [197](/filings/0001193125-25-253579.md) | [189 d](/filings/0001193125-26-062397.md) | [202](/filings/0001193125-26-209016.md) | [202](/filings/0001193125-26-323769.md) | [201](/filings/0001193125-25-253579.md) | [203 d](/filings/0001193125-26-062397.md) | [265](/filings/0001193125-26-209016.md) | [320](/filings/0001193125-26-323769.md) |
| Operating income | $m | [56.3](/filings/0000950170-24-118254.md) | [43.5 d](/filings/0001193125-26-062397.md) | [0.8](/filings/0000950170-25-061080.md) | [22.8](/filings/0000950170-25-099646.md) | [5.3](/filings/0001193125-25-253579.md) | [2.6 d](/filings/0001193125-26-062397.md) | [2.3](/filings/0001193125-26-209016.md) | [5.8](/filings/0001193125-26-323769.md) | [(1.0)](/filings/0001193125-25-253579.md) | [(37.9) d](/filings/0001193125-26-062397.md) | [23.2](/filings/0001193125-26-209016.md) | [34.4](/filings/0001193125-26-323769.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [12.9](/filings/0000950170-24-118254.md) | [7.5 d](/filings/0001193125-26-062397.md) | [(2.1)](/filings/0000950170-25-061080.md) | [3.0](/filings/0000950170-25-099646.md) | [(0.4)](/filings/0001193125-25-253579.md) | [(0.6) d](/filings/0001193125-26-062397.md) | [(1.6)](/filings/0001193125-26-209016.md) | [(8.4)](/filings/0001193125-26-323769.md) | [4.1](/filings/0001193125-25-253579.md) | [(10.2) d](/filings/0001193125-26-062397.md) | [8.2](/filings/0001193125-26-209016.md) | [6.0](/filings/0001193125-26-323769.md) |
| Net income | $m | [35.0](/filings/0000950170-24-118254.md) | [25.8 d](/filings/0001193125-26-062397.md) | [(7.6)](/filings/0000950170-25-061080.md) | [9.9](/filings/0000950170-25-099646.md) | [(6.6)](/filings/0001193125-25-253579.md) | [(4.3) d](/filings/0001193125-26-062397.md) | [(5.6)](/filings/0001193125-26-209016.md) | [1.9](/filings/0001193125-26-323769.md) | [(14.8)](/filings/0001193125-25-253579.md) | [(37.9) d](/filings/0001193125-26-062397.md) | [4.5](/filings/0001193125-26-209016.md) | [15.5](/filings/0001193125-26-323769.md) |
| Diluted EPS | $ per share | [1.00](/filings/0000950170-24-118254.md) | not reported | [(0.22)](/filings/0000950170-25-061080.md) | [0.29](/filings/0000950170-25-099646.md) | [(0.20)](/filings/0001193125-25-253579.md) | not reported | [(0.18)](/filings/0001193125-26-209016.md) | [0.06](/filings/0001193125-26-323769.md) | [(0.46)](/filings/0001193125-25-253579.md) | not reported | [0.10](/filings/0001193125-26-209016.md) | [0.30](/filings/0001193125-26-323769.md) |
| Basic EPS | $ per share | [1.02](/filings/0000950170-24-118254.md) | not reported | [(0.22)](/filings/0000950170-25-061080.md) | [0.29](/filings/0000950170-25-099646.md) | [(0.20)](/filings/0001193125-25-253579.md) | not reported | [(0.18)](/filings/0001193125-26-209016.md) | [0.06](/filings/0001193125-26-323769.md) | [(0.46)](/filings/0001193125-25-253579.md) | not reported | [0.11](/filings/0001193125-26-209016.md) | [0.30](/filings/0001193125-26-323769.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [37.4](/filings/0000950170-23-056356.md) | [54.3](/filings/0000950170-25-024199.md) | [41.9](/filings/0000950170-24-050548.md) | [28.0](/filings/0000950170-24-087880.md) | [35.0](/filings/0000950170-24-118254.md) | [27.7](/filings/0001193125-26-062397.md) | [33.6](/filings/0000950170-25-061080.md) | [30.8](/filings/0000950170-25-099646.md) | [29.8](/filings/0001193125-25-253579.md) | [26.9](/filings/0001193125-26-323769.md) | [25.1](/filings/0001193125-26-209016.md) | [41.9](/filings/0001193125-26-323769.md) |
| Current assets | $m | [1,359](/filings/0000950170-23-056356.md) | [1,383](/filings/0000950170-25-024199.md) | [1,525](/filings/0000950170-24-050548.md) | [1,389](/filings/0000950170-24-087880.md) | [1,301](/filings/0000950170-24-118254.md) | [1,208](/filings/0001193125-26-062397.md) | [1,298](/filings/0000950170-25-061080.md) | [1,325](/filings/0000950170-25-099646.md) | [1,304](/filings/0001193125-25-253579.md) | [1,223](/filings/0001193125-26-323769.md) | [2,111](/filings/0001193125-26-209016.md) | [2,267](/filings/0001193125-26-323769.md) |
| Total assets | $m | [2,434](/filings/0000950170-23-056356.md) | [2,570](/filings/0000950170-25-024199.md) | [2,720](/filings/0000950170-24-050548.md) | [2,591](/filings/0000950170-24-087880.md) | [2,533](/filings/0000950170-24-118254.md) | [2,440](/filings/0001193125-26-062397.md) | [2,524](/filings/0000950170-25-061080.md) | [2,538](/filings/0000950170-25-099646.md) | [2,490](/filings/0001193125-25-253579.md) | [2,405](/filings/0001193125-26-323769.md) | [3,724](/filings/0001193125-26-209016.md) | [3,842](/filings/0001193125-26-323769.md) |
| Current liabilities | $m | [634](/filings/0000950170-23-056356.md) | [634](/filings/0000950170-25-024199.md) | [729](/filings/0000950170-24-050548.md) | [583](/filings/0000950170-24-087880.md) | [585](/filings/0000950170-24-118254.md) | [580](/filings/0001193125-26-062397.md) | [647](/filings/0000950170-25-061080.md) | [651](/filings/0000950170-25-099646.md) | [657](/filings/0001193125-25-253579.md) | [668](/filings/0001193125-26-323769.md) | [954](/filings/0001193125-26-209016.md) | [1,028](/filings/0001193125-26-323769.md) |
| Total liabilities | $m | [1,543](/filings/0000950170-23-056356.md) | [1,655](/filings/0000950170-25-024199.md) | [1,823](/filings/0000950170-24-050548.md) | [1,705](/filings/0000950170-24-087880.md) | [1,691](/filings/0000950170-24-118254.md) | [1,615](/filings/0001193125-26-062397.md) | [1,710](/filings/0000950170-25-061080.md) | [1,717](/filings/0000950170-25-099646.md) | [1,693](/filings/0001193125-25-253579.md) | [1,641](/filings/0001193125-26-323769.md) | [2,431](/filings/0001193125-26-209016.md) | [2,543](/filings/0001193125-26-323769.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | [5.9](/filings/0000950170-23-056356.md) | [8.2](/filings/0000950170-25-024199.md) | [3.7](/filings/0000950170-24-050548.md) | [1.4](/filings/0000950170-24-087880.md) | [1.8](/filings/0000950170-24-118254.md) | [0.7](/filings/0001193125-26-062397.md) | [0.3](/filings/0000950170-25-061080.md) | [1.4](/filings/0000950170-25-099646.md) | [1.5](/filings/0001193125-25-253579.md) | [1.9](/filings/0001193125-26-323769.md) | [2.6](/filings/0001193125-26-209016.md) | [2.6](/filings/0001193125-26-323769.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [883](/filings/0000950170-23-056356.md) | [906](/filings/0000950170-25-024199.md) | [889](/filings/0000950170-24-050548.md) | [878](/filings/0000950170-24-087880.md) | [833](/filings/0000950170-24-118254.md) | [815](/filings/0001193125-26-062397.md) | [804](/filings/0000950170-25-061080.md) | [812](/filings/0000950170-25-099646.md) | [787](/filings/0001193125-25-253579.md) | [753](/filings/0001193125-26-323769.md) | [1,282](/filings/0001193125-26-209016.md) | [1,288](/filings/0001193125-26-323769.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [79.3 d](/filings/0000950170-24-118254.md) | [90.1 d](/filings/0001193125-26-062397.md) | [(47.8)](/filings/0000950170-25-061080.md) | [25.9 d](/filings/0000950170-25-099646.md) | [135 d](/filings/0001193125-25-253579.md) | [92.2 d](/filings/0001193125-26-062397.md) | [(41.2)](/filings/0001193125-26-209016.md) | [38.8 d](/filings/0001193125-26-323769.md) | [(23.3) d](/filings/0001193125-25-253579.md) | [113 d](/filings/0001193125-26-062397.md) | [(179)](/filings/0001193125-26-209016.md) | [21.4 d](/filings/0001193125-26-323769.md) |
| Capital expenditure | $m | [22.4 d](/filings/0000950170-24-118254.md) | [25.4 d](/filings/0001193125-26-062397.md) | [21.8](/filings/0000950170-25-061080.md) | [22.7 d](/filings/0000950170-25-099646.md) | [31.6 d](/filings/0001193125-25-253579.md) | [23.5 d](/filings/0001193125-26-062397.md) | [8.0](/filings/0001193125-26-209016.md) | [9.9 d](/filings/0001193125-26-323769.md) | [12.8 d](/filings/0001193125-25-253579.md) | [20.8 d](/filings/0001193125-26-062397.md) | [12.2](/filings/0001193125-26-209016.md) | [16.3 d](/filings/0001193125-26-323769.md) |
| Dividends paid | $m | [6.3 d](/filings/0000950170-24-118254.md) | [6.3 d](/filings/0001193125-26-062397.md) | [6.4](/filings/0000950170-25-061080.md) | [6.4 d](/filings/0000950170-25-099646.md) | [6.0 d](/filings/0001193125-25-253579.md) | [6.0 d](/filings/0001193125-26-062397.md) | [6.0](/filings/0001193125-26-209016.md) | [6.0 d](/filings/0001193125-26-323769.md) | [6.0 d](/filings/0001193125-25-253579.md) | [6.1 d](/filings/0001193125-26-062397.md) | [9.7](/filings/0001193125-26-209016.md) | [9.7 d](/filings/0001193125-26-323769.md) |
| Share repurchases | $m | [4.0 d](/filings/0000950170-24-118254.md) | [6.3 d](/filings/0001193125-26-062397.md) | [1.0](/filings/0000950170-25-061080.md) | [14.0 d](/filings/0000950170-25-099646.md) | [36.0 d](/filings/0001193125-25-253579.md) | [0.0 d](/filings/0001193125-26-062397.md) | not reported | not reported | not reported | not reported | [1.6](/filings/0001193125-26-209016.md) | [0.8 d](/filings/0001193125-26-323769.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [37.8](/filings/0000950170-23-056356.md) | [37.2](/filings/0000950170-24-050548.md) | [35.5](/filings/0000950170-24-087880.md) | [34.9](/filings/0000950170-24-118254.md) | [34.0](/filings/0000950170-25-061080.md) | [34.4](/filings/0000950170-25-099646.md) | [32.7](/filings/0001193125-25-253579.md) | [31.9](/filings/0001193125-26-209016.md) | [32.4](/filings/0001193125-26-323769.md) | [32.2](/filings/0001193125-25-253579.md) | [43.2](/filings/0001193125-26-209016.md) | [52.6](/filings/0001193125-26-323769.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 51,898,653 at 2026-07-24, from the cover of the [10-Q filed 2026-07-29](/filings/0001193125-26-323769.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.